FURTHER INVESTIGATIONS OF THE CHEMOTHERAPY OF RADIATION SICKNESS IN EXPERIMENTS ON MONKEYS

Journal Article · Wed Jan 01 00:00:00 EST 1958 · J. Microbiol. Epidemiol. Immunobiol. (USSR)(English Translation)

OSTI ID:4275432

Tumanian, M A

>The rational use of chemotherapy in the treatment of radiation siekness prevents the development of postradiational bacteremia and the transformation of a latent chronic dysentery in monkeys into a clinically apparent acute form of the disease. Chemotherapy has a favorable effect on the outcome of radiation sickness in monkeys, preserving the lives of a large proportion of the animals even when exposed to an absolute lethal dose of x rays. Streptomycin in the principal therapeutic program suggested for radiation sickness can be replaced by other antibiotics, albomycin and colimycin, or by the sulfonamide drug phthalylsulfathiazole. (auth)

• Research Organization: Gamaleia Inst. of Epidemiology and Microbiology, Academy of Medical Sciences of the U.S.S.R.
• NSA Number: NSA-13-011576
• OSTI ID: 4275432
• Journal Information: J. Microbiol. Epidemiol. Immunobiol. (USSR)(English Translation), Vol. Vol: 29; Other Information: Orig. Receipt Date: 31-DEC-59
• Country of Publication: Country unknown/Code not available
• Language: English

Related Subjects

BIOLOGY AND MEDICINE
ANTIBIOTICS
BACTERIA
BLOOD
CHEMOTHERAPY
DRUGS
INFECTIONS
INTESTINE
LETHAL DOSE
MEDICINE
MONKEYS
STREPTOMYCIN
SULFONAMIDES
SURVIVAL TIME
THERAPY
THICKNESS
X RADIATION